Clozaril
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Objective Clozapine is the treatment of choice for refractory schizophrenia. The aim of this study was to compare the…
To investigate the bioequivalence of the three clozapine brands licensed in the United Kingdom, we compared plasma clozapine and…
This study prospectively assessed outcomes in a group of patients who were randomly switched from Clozaril to generic clozapine…
ABSTRACT. The antipsychotic agent clozapine (Clozaril®) is reserved for the treatment of refractory psychosis. Clozapine has…
Summary Two generic preparations of clozapine have been licensed in the UK. The bioequivalence of these products compared with…
As a consequence of its prevalence, early onset and chronicity, schizophrenia imposes clinical and economic impediments to…
OBJECTIVE: To evaluate safety and dosage requirements when patients taking brand-name clozapine (Clozaril, Novartis…
AbstractObjective: This inpatient, randomised, three-way crossover study evaluated the steady-state pharmacokinetics and…
1. Clozaril, an atypical antipsychotic, did not gain approval for use in Australia until 1992. Prior to its general release, a…
Clozaril, an antipsychotic agent, has several harmful side effects. An established computerized database was used to monitor…